Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Messina, Maria
NCT06694168: Efficacy of the Entire Papilla Preservation Technique With and Without the Use of L-PRF as a Regenerative Material for the Treatment of Infrabony Defects	Recruiting	N/A	30	RoW	Periodontal Regeneration, clinical and radiographic results, modified minimal invasive surgery, REGEND001 Autologous Therapy Product	Universidad de los Andes, Chile	Periodontal Regeneration, Minimally Invasive Surgical Technique, Platelet Rich Fibrin, Microsurgery, Periodontal Intrabony Defect, Periodontal Disease	06/26	06/26
Pollio, Berardino
NCT05582993 / 2020-003304-13: A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)	Recruiting	3	24	Europe, Japan, US	Vonicog Alfa, TAK-577, Recombinant von Willebrand Factor (rVWF), Vonvendi-Veyvondi, ADVATE, Recombinant Factor VIII (rFVIII), Octocog Alfa	Takeda, Takeda Development Center Americas, Inc.	Von Willebrand Disease (VWD)	04/30	04/30
Protect-NOW, NCT03695978: Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia a Patients	Recruiting	N/A	200	Europe, Canada, US, RoW		Octapharma	Haemophilia a	06/30	06/30

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Messina, Maria
NCT06694168: Efficacy of the Entire Papilla Preservation Technique With and Without the Use of L-PRF as a Regenerative Material for the Treatment of Infrabony Defects	Recruiting	N/A	30	RoW	Periodontal Regeneration, clinical and radiographic results, modified minimal invasive surgery, REGEND001 Autologous Therapy Product	Universidad de los Andes, Chile	Periodontal Regeneration, Minimally Invasive Surgical Technique, Platelet Rich Fibrin, Microsurgery, Periodontal Intrabony Defect, Periodontal Disease	06/26	06/26
Pollio, Berardino
NCT05582993 / 2020-003304-13: A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)	Recruiting	3	24	Europe, Japan, US	Vonicog Alfa, TAK-577, Recombinant von Willebrand Factor (rVWF), Vonvendi-Veyvondi, ADVATE, Recombinant Factor VIII (rFVIII), Octocog Alfa	Takeda, Takeda Development Center Americas, Inc.	Von Willebrand Disease (VWD)	04/30	04/30
Protect-NOW, NCT03695978: Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia a Patients	Recruiting	N/A	200	Europe, Canada, US, RoW		Octapharma	Haemophilia a	06/30	06/30